Gadoterate Meglumine Injection shortage
To Be Discontinued 8 presentations · 1 manufacturers · first FDA posting May 21, 2026 · last update Jun 30, 2026
Manufacturers: Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Stated reasons (per FDA): Not stated
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Gadoterate Meglumine, Injection, 376.9 mg/1 mL (NDC 65219-080-05) | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | To Be Discontinued | — | Marketed by Fresenius Kabi, USA; Discontinuation of the manufacture of the drug | Posted Jun 30, 2026 Updated Jun 30, 2026 Discontinued Jun 30, 2026 |
| Gadoterate Meglumine, Injection, 376.9 mg/1 mL (NDC 65219-080-05) | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted May 21, 2026 Updated May 21, 2026 Discontinued May 21, 2026 |
| Gadoterate Meglumine, Injection, 376.9 mg/1 mL (NDC 65219-082-10) | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | To Be Discontinued | — | Marketed by Fresenius Kabi, USA; Discontinuation of the manufacture of the drug | Posted Jun 30, 2026 Updated Jun 30, 2026 Discontinued Jun 30, 2026 |
| Gadoterate Meglumine, Injection, 376.9 mg/1 mL (NDC 65219-082-10) | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted May 21, 2026 Updated May 21, 2026 Discontinued May 21, 2026 |
| Gadoterate Meglumine, Injection, 376.9 mg/1 mL (NDC 65219-084-15) | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | To Be Discontinued | — | Marketed by Fresenius Kabi, USA; Discontinuation of the manufacture of the drug | Posted Jun 30, 2026 Updated Jun 30, 2026 Discontinued Jun 30, 2026 |
| Gadoterate Meglumine, Injection, 376.9 mg/1 mL (NDC 65219-084-15) | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted May 21, 2026 Updated May 21, 2026 Discontinued May 21, 2026 |
| Gadoterate Meglumine, Injection, 376.9 mg/1 mL (NDC 65219-086-20) | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | To Be Discontinued | — | Marketed by Fresenius Kabi, USA; Discontinuation of the manufacture of the drug | Posted Jun 30, 2026 Updated Jun 30, 2026 Discontinued Jun 30, 2026 |
| Gadoterate Meglumine, Injection, 376.9 mg/1 mL (NDC 65219-086-20) | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted May 21, 2026 Updated May 21, 2026 Discontinued May 21, 2026 |